Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

Epstein, Judith E; Gorak, Edward J; Charoenvit, Yupin; Wang, Ruobing; Freydberg, Nicole; Osinowo, Oluwatoyin; Richie, Thomas L; Stoltz, Erin L; Trespalacios, Fernando; Nerges, John; Ng, Jennifer; Fallarme-Majam, Victoria; Abot, Esteban; Goh, Lucy; Parker, Suezanne; Kumar, Sanjai; Hedstrom, Richard C; Norman, Jon; Stout, Richard; Hoffman, Stephen L

Epstein, Judith E; Gorak, Edward J; Charoenvit, Yupin; Wang, Ruobing; Freydberg, Nicole; Osinowo, Oluwatoyin; Richie, Thomas L; Stoltz, Erin L; Trespalacios, Fernando; Nerges, John; Ng, Jennifer; Fallarme-Majam, Victoria; Abot, Esteban; Goh, Lucy; Parker, Suezanne; Kumar, Sanjai; Hedstrom, Richard C; Norman, Jon; Stout, Richard; Hoffman, Stephen L.

Afiliação

Epstein JE; Malaria Program, Naval Medical Research Center, Silver Spring, MD 20910, USA. epsteinj@nmrc.navy.mil

Hum Gene Ther ; 13(13): 1551-60, 2002 Sep 01.

Article em En | MEDLINE | ID: mdl-12228010

Assuntos

Malária/prevenção & controle; Vacinas de DNA/administração & dosagem; Animais; Humanos; Injeções Intradérmicas; Injeções Intramusculares; Malária/imunologia; Plasmodium falciparum/imunologia; Vacinas de DNA/efeitos adversos; Vacinas de DNA/imunologia

Buscar no Google

Imprimir

XML

PubMed Links